Transplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationAntigens, CD34Peripheral Blood Stem Cell TransplantationGranulocyte Colony-Stimulating FactorLymphoma, Non-HodgkinLeukapheresisHematopoietic Stem CellsBone Marrow PurgingHodgkin DiseaseGraft SurvivalPlatelet CountHematopoiesisCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsBlood Component RemovalLymphomaThiotepaCyclophosphamideBlood Cell CountMelphalanCarmustineCytapheresisEtoposideMultiple MyelomaTransplantation ConditioningHematologic NeoplasmsBone Marrow TransplantationColony-Forming Units AssayBlood Transfusion, AutologousIfosfamideStem CellsRecombinant ProteinsCytarabineCell SeparationTreatment OutcomeBlood CellsStem Cell FactorMetrizoateTransplantation, HomologousGranulocyte-Macrophage Colony-Stimulating FactorLeukocyte CountLymphoma, T-CellSalvage TherapyImmunomagnetic SeparationBreast NeoplasmsAntineoplastic Agents, AlkylatingLymphoma, B-CellCarboplatinNeoplasmsVincristineRemission InductionDoxorubicinBone MarrowTime FactorsBone Marrow CellsCells, CulturedFlow CytometryHematopoietic Cell Growth FactorsImmunophenotypingDisease-Free SurvivalWhole-Body IrradiationLymphoma, Large B-Cell, DiffuseAntigens, CDPlatelet TransfusionLeukocytes, MononuclearCell CountFeasibility StudiesBlood Component TransfusionReed-Sternberg CellsGraft vs Host DiseaseRetrospective StudiesRecurrenceThrombopoietinCell DifferentiationLeukemiaBlood PreservationInterleukin-3Blood DonorsLymphoma, FollicularCryopreservationStem Cell TransplantationMitoxantroneSurvival RateHematologic DiseasesBusulfanMyeloablative AgonistsNeoplasm, ResidualProspective StudiesNeutropeniaAntineoplastic AgentsT-LymphocytesCytophagocytosisEpirubicinBurkitt LymphomaFollow-Up StudiesCosts and Cost AnalysisSurvival AnalysisPolymerase Chain Reaction